Medical Devices

Advanced Medical Optics reports on U.S. launch of Tecnis Multifocal intraocular lens

Published in Medical Letter on the CDC and FDA, February 4th, 2007

Advanced Medical Optics, Inc., (AMO, EYE), a global ophthalmic surgical and eye care products company, announced that the U.S. Food and Drug Administration (FDA) has recommended that the company enroll additional subjects in its U.S. clinical study for the Tecnis Multifocal intraocular lens (IOL).

AMO still intends to file a premarket approval (PMA) application for the Tecnis Multifocal IOL next month in accordance with its original plan to launch the product in the U.S. in the first half of 2008. However, in light of the latest questions raised by the FDA, the company now believes there is a reasonable likelihood the launch timeline could be extended by approximately...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2007-02-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry